OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML
Mariam T. Nawas, Satyajit Kosuri
Blood Advances (2023) Vol. 8, Iss. 3, pp. 553-561
Open Access | Times Cited: 16

TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
Dong‐Yeop Shin
Cancers (2023) Vol. 15, Iss. 19, pp. 4816-4816
Open Access | Times Cited: 15

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Guadalupe Oñate, Ana Garrido, Montserrat Arnán, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access

Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients
Yasutaka Masuda, Daichi Sadato, Takashi Toya, et al.
International Journal of Hematology (2025)
Closed Access

Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions
Eitan Kugler, Enes Dasdemir, Álex Bataller, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-13
Closed Access

Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis
Ashley E. Culver‐Cochran, Aishlin Hassan, Kathleen Hueneman, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment
Monika Chomczyk, Luca Gazzola, Shubhankar Dash, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experience
Kittika Poonsombudlert, Sarah L. Mott, B. E. Miller, et al.
European Journal Of Haematology (2024) Vol. 113, Iss. 1, pp. 16-23
Open Access

Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions
Paul Sackstein, Alexis K. Williams, Rachel Zemel, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 975-975
Open Access

Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak, Madina Sukhanova, Juehua Gao, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-7
Closed Access

Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?
Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 12, pp. 1777-1788
Closed Access

Unmet Horizons: Assessing the Challenges in the Treatment of TP53-Mutated Acute Myeloid Leukemia
Christos Stafylidis, Dimitra Vlachopoulou, Christina‐Nefeli Kontandreopoulou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1082-1082
Open Access

Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC)
Clémence Médiavilla, Maud D’Aveni, Anne Huynh, et al.
Bulletin du Cancer (2024)
Closed Access

Page 1

Scroll to top